Novartis’s high-tech command center in Basel, Switzerland, tracks its global drug trials. (Photographer: Stefan Wermuth/Bloomberg)
(Bloomberg Businessweek) -- Discoveries of new cancer-fighting and antiviral medicines grab headlines and sometimes win Nobel Prizes. But after the breakthroughs and backslapping are over, Big Pharma’s grunt work is just beginning.